Death Risk Up for Hospitalized Cannabis Users With Arrhythmias
THURSDAY, May 13, 2021 -- Hospitalized patients who use cannabis and have an arrhythmia have worse outcome than cannabis users without arrhythmias, according to a study presented at EHRA 2021, an online scientific congress hosted by the European Society of Cardiology.
Harshith Thyagaturu, M.B., B.S., from the Bassett Healthcare Network in Cooperstown, New York, and colleagues used data from the National Inpatient Sample database to identify 2,457,544 adult cannabis users admitted to the hospital from 2016 to 2018. Deaths were compared between those with arrhythmias and those without.
The researchers found that 7.6 percent of hospitalized cannabis users had an arrhythmia, most commonly atrial fibrillation followed by abnormally slow heart rate and abnormally fast heart rate. Those with arrhythmias had significantly more comorbidities. Cannabis users with an arrhythmia had a significantly higher odds ratio of in-hospital mortality (adjusted odds ratio, 4.5) as well as a longer length of stay (5.7 versus 5.1 days).
"People should be aware of this devastating outcome and be careful when using cannabis if they have a concomitant heart problem," a coauthor said in a statement.
© 2021 HealthDay. All rights reserved.
Posted May 2021
Read this next
FRIDAY, May 14, 2021 -- The U.S. Food and Drug Administration is warning that strong magnets in some cellphones and smartwatches can interfere with pacemakers and other implanted...
FRIDAY, May 14, 2021 -- New-onset anxiety and depression are common in the two years following the first-time placement of an implantable cardioverter defibrillator (ICD)...
WEDNESDAY, April 28, 2021 -- COVID-19 infection is associated with significant mean QTc prolongation at days 2 and 5 of hospitalization, according to a study published online...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.